No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
暂无分享,去创建一个
T. Werge | U. Vogel | H. Rasmussen | A. Vangsted | T. Klausen | N. Abildgaard | K. Søeby | N. F. Andersen | P. Gimsing | H. Gregersen